BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Modulus Therapeutics

Modulus Therapeutics logo

Founded
2020

Technologies

AI Companies (Drug Discovery)

Modulus is engineering next-generation immune cell therapies, starting with Natural Killer cells rationally designed for the treatment of solid tumors. Convergent DesignTM combines genetic engineering, machine learning, and high-throughput in vivo screening to systematically converge on optimized cell designs. Modulus is committed to the discovery of cell therapies to treat a broad set of patient populations not currently served by existing treatments and plans on using its platform to both develop an internal pipeline of therapeutics as well as enable partners.

Become a Member to view additional information about this company